HEALTH● LOW2h ago · Sep 28, 2026, 12:19 PM
AbbVie’s Juvmo wins FDA approval for Parkinson’s disease
Seeking Alpha Tech · global
AbbVie's Juvmo has received FDA approval for the treatment of Parkinson's disease. This marks a significant development for patients and the medical community in finding new treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH31m agoGermany news: COVID vaccine maker BioNTech to close 3 sitesDW News [en]HEALTH49m ago'We can solve this problem': Renewed hope of replacing dirty cooking fuels that kill millions every yearEuroNews [en]HEALTH1h agoChildren sickened in E. coli outbreak linked to recalled raw milk cheeseThe Independent WorldHEALTH1h agoCan birdwatching help stroke recovery? Researchers say it could aid communication skillsEuroNews [en]